Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Gives Genomic Solutions 90 Days to Shape Up

NEW YORK, June 14 - The Nasdaq market has issued Genomic Solutions a "deficiency notice" because its stock has failed to stay above $1 for 30 consecutive days, the company said today.

 

Genomic Solutions said the notice does not affect its stock, which was trading at $.72 this afternoon.

 

The company has 90 days to bring the stock to $1, for which it said it is "evaluating alternatives."